Woodline Partners LP - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 170 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$5,251,532
+164.4%
339,905
+876.8%
0.07%
+34.0%
Q4 2020$1,986,000
+40.9%
34,797
+53.6%
0.05%
-8.6%
Q4 2019$1,410,00022,6600.06%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$69,030,00015.95%
SV Health Investors, LLC 449,951$25,679,00012.37%
Sunesis Advisors, LLC 96,299$5,496,0004.45%
Redmile Group, LLC 4,437,968$253,275,0003.07%
Consonance Capital Management LP 484,671$27,660,0002.58%
SECTORAL ASSET MANAGEMENT INC 488,842$27,898,0001.97%
Opaleye Management Inc. 222,000$12,670,0001.66%
Eversept Partners, LP 246,240$14,052,9171.65%
SILVERARC CAPITAL MANAGEMENT, LLC 38,620$2,204,0001.28%
Avoro Capital Advisors LLC 1,300,000$74,191,0001.28%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders